基本属性 生物活性靶点体外研究体内研究 用途与合成方法 228266-41-9 价格(试剂级) 供应商

228266-41-9

228266-41-9

中文名称:228266-41-9
英文名称:Taltobulin (trifluoroacetate)
CAS号:228266-41-9
分子式:C29H44F3N3O6
分子量:587.6713696
EINECS号:
Mol文件:228266-41-9.mol
228266-41-9 结构式

228266-41-9 性质

储存条件 Store at -20°C
溶解度 二甲基亚砜:≥39mg/mL(66.36mM)

228266-41-9 用途与合成方法

Taltobulin trifluoroacetate (HTI-286 trifluoroacetate) 是一种合成的三肽半胱氨酸类似物,Taltobulin 是一种有效的抗微管剂 (antimicrotubule),可在体内外规避 P-糖蛋白介导的耐药性。Taltobulin trifluoroacetate 抑制纯化的微管蛋白聚合,破坏细胞中的微管组织,并诱导有丝分裂停滞以及凋亡 (apoptosis)。

Traditional Cytotoxic Agents

Taltobulin (HTI-286; 0.2-7.3 nM; 3 days) inhibits the growth of 18 tumor cell lines (leukemia, ovarian, NSCLC, breast, colon, and melanoma cell lines) with an average IC 50 of 2.5±2.1 nM and a median value of 1.7 nM.

Cell Proliferation Assay

Cell Line: Leukemia CCRF-CEM cell line; ovarian 1A9 cell line; NSCLC A549 and NCI-H1299 cell lines; breast MX-1W and MCF-7 cell lines; colon HCT-116, DLD-1, Colo205, KM20, SW620, S1, HCT-15 and Moser cell lines; melanoma A375, Lox and SK-Mel-2 cell lines
Concentration: 0.2-7.3 nM
Incubation Time: 3 days
Result: Inhibited the growth of tumor cell lines with IC 50 s of 0.2±0.03 nM (for leukemia CCRF-CEM cell line), 0.6±0.1 nM (for ovarian 1A9 cell line), 1.1±0.5 and 6.8±6.1 nM ( for NSCLC A549 and NCI-H1299 cell lines), 1.8±0.6, 7.3±2.3 nM (for breast MX-1W, MCF-7 cell lines), 0.7±0.2, 1.1±0.4, 1.5±0.6, 1.8±0.6, 3.6±0.8, 3.7±2.0, 4.2±2.5, and 5.3±4.1 nM ( for colon HCT-116, DLD-1, Colo205, KM20, SW620, S1, HCT-15, and Moser cell lines), 1.1±0.8, 1.4±0.6 and 1.7±0.5 nM (for melanoma A375, Lox and SK-Mel-2 cell lines).

Taltobulin (HTI-286; 1.6 mg/kg i.v.) inhibits the growth of human tumor xenografts (e.g., HCT-15, DLD-1, MX-1W, and KB-8-5) in athymic nu/nu female mice.
Taltobulin (HTI-286; 3 mg/kg; p.o. gavage) inhibits growth by 97.3 % and 82% in athymic nu/nu female mice with Lox melanoma xenografts and KB-3-1 epidermoid xenograft model, respectively.

Animal Model: Athymic nu/nu female mice with Lox melanoma model (5-6 weeks of age)
Dosage: 1.6 mg/kg
Administration: Administered i.v.;for 35 days
Result: Growth of Lox tumors was inhibited by 96-98% on day 12 compared with vehicle-treated controls.
Growth of KB-8-5 tumors was inhibited by 84% on day 14 compared with vehicle-treated controls.
Growth of MX-1W tumors was inhibited by 97% compared with vehicle-treated controls.
Growth of DLD-1 and HCT-15 tumors was inhibited by 80 and 66%, respectively.

228266-41-9 价格(试剂级)

更新日期 产品编号 产品名称 CAS号 包装 价格
2024-04-30 HY-15584A 228266-41-9 228266-41-9 5mg 2750
2024-04-30 HY-15584A 228266-41-9 228266-41-9 10mM * 1mLin DMSO 3555

228266-41-9供应商 更多

北京普西唐生物科技有限公司
联系电话:010-60605840 18892239720
产品介绍:
英文名称:Taltobulin trifluoroacetate
CAS:228266-41-9
纯度:98%
包装信息:5mg
ChemeGen 中国
联系电话: 18818260767
产品介绍:
英文名称:Taltobulin trifluoroacetate
CAS:228266-41-9
纯度:98%
包装信息:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
备注:品牌:ChemeGen
爱必信(上海)生物科技有限公司
联系电话:021-38015121 15000105423
产品介绍:
英文名称:Taltobulin trifluoroacetate
CAS:228266-41-9
纯度:98%
包装信息:5mg;10mg
天津普西唐生物医药科技有限公司
联系电话:010-60605840
产品介绍:
英文名称:Taltobulin trifluoroacetate
CAS:228266-41-9
纯度:98%
包装信息:5mg
InvivoChem中国
联系电话: 13549236410
产品介绍:
英文名称:Taltobulin trifluoroacetate
CAS:228266-41-9
纯度:>=98%
包装信息:98%
备注:V31385